Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Poly(lactic acid) (
PLA
)/Polybutylene adipate co-terephthalate (PBAT) blend and its nanocomposites were prepared using melt blending technique.
Glycidyl methacrylate
(
GMA
) has been used as a reactive compatibilizer to improve the interface between
PLA
and PBAT. Mechanical studies indicated an increase in impact strength and tensile modulus of
PLA
matrix with the increase in PBAT loading.
PLA
/PBAT blend prepared at ratio of 75:25 exhibited optimum impact strength. Further, incorporation of
GMA
to the tune of 5wt.% and nanoclay shows an increase of impact strength. Morphological interpretations through SEM reveals improved interfacial adhesion between the
PLA
/PBAT blend in presence of
GMA
and nanoclay. XRD studies indicated an increase in d-spacing in
PLA
/PBAT/C20A blend nanocomposite thus revealing intercalated morphology. DSC and TGA thermograms also showed improved thermal properties as compared with virgin
PLA
. DMA tests revealed an increase in damping factor, confirming strong influence between
PLA
/PBAT blend in presence of
GMA
and nanoclay.
...
PMID:Effect of glycidyl methacrylate (GMA) on the thermal, mechanical and morphological property of biodegradable PLA/PBAT blend and its nanocomposites. 2057 2
